CCL2 and chronic kidney disease: Similarly, elevated YAP levels have been shown to exacerbate macrophage infiltration and MCP-1 expression in other studies such as with liver injury (63), acute kidney injury-chronic kidney disease (AKI-CKD) transition (64), and atherosclerosis (65).